TerrAscend Corp TSND
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TSND is a good fit for your portfolio.
News
-
Cannabis stocks pull back after rallying on DEA's plans to reclassify marijuana
-
Cannabis stocks rally after report that DEA will reclassify drug as less dangerous
-
Sometimes Legends Come in Small Packages
-
TerrAscend to Host First Quarter 2024 Earnings Conference Call
-
What New Jersey did right - and New York did wrong - with recreational-cannabis launches
-
TerrAscend Reports Fourth Quarter and Full Year 2023 Financial Results
-
Cannabis stocks rise after President Biden mentions plant in State of the Union speech
-
TerrAscend to Host Fourth Quarter and Full Year 2023 Earnings Conference Call
Trading Information
- Previous Close Price
- CAD 2.46
- Day Range
- CAD 2.35–2.50
- 52-Week Range
- CAD 1.72–3.21
- Bid/Ask
- CAD 2.37 / CAD 2.43
- Market Cap
- CAD 699.62 Mil
- Volume/Avg
- 295,123 / 355,707
Key Statistics
- Price/Earnings (Normalized)
- 23.86
- Price/Sales
- 1.60
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 36
- Website
- https://www.terrascend.com
Comparables
Valuation
Metric
|
TSND
|
VIT
|
AMANAT
|
---|---|---|---|
Price/Earnings (Normalized) | 23.86 | 7.43 | 131.26 |
Price/Book Value | 2.20 | 1.83 | 0.98 |
Price/Sales | 1.60 | 0.59 | 3.10 |
Price/Cash Flow | — | 6.39 | 14.11 |
Price/Earnings
TSND
VIT
AMANAT
Financial Strength
Metric
|
TSND
|
VIT
|
AMANAT
|
---|---|---|---|
Quick Ratio | 0.21 | 1.15 | — |
Current Ratio | 0.50 | 1.39 | — |
Interest Coverage | −0.68 | 32.25 | — |
Quick Ratio
TSND
VIT
AMANAT
Profitability
Metric
|
TSND
|
VIT
|
AMANAT
|
---|---|---|---|
Return on Assets (Normalized) | 2.75% | 16.65% | 3.54% |
Return on Equity (Normalized) | 6.75% | 27.17% | 4.93% |
Return on Invested Capital (Normalized) | 8.44% | 22.87% | — |
Return on Assets
TSND
VIT
AMANAT
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Cqrjgjqqq | Tfff | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Bjjjcccdv | Wmvbbdg | $69.1 Bil | |
HLN
| Haleon PLC ADR | Wbrxfxxgl | Vfpj | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Qqlcgxkv | Wfcg | $15.7 Bil | |
VTRS
| Viatris Inc | Gvyqhxlr | Kngj | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Nfzyzxh | Ssvq | $12.4 Bil | |
CTLT
| Catalent Inc | Rfsygsbj | Qrpzsq | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qvzldktdk | Hbn | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Tqwdcsng | Ddhqs | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Lbfkmvxc | Nfmzg | $3.5 Bil |